Asahi Intecc (7747) · InitiativeRestated
KANEKA CORPORATION Enters into U.S. Sales Partnership for New Cerebral Aneurysm Embolization Coil
First written in FY2022-Q1. 1 of 2 entries say "Restated". Latest entry: FY2022-Q2.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
US sales partnership for Kaneka's new cerebral aneurysm embolization coilA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2022-Q2RestatedAnnual report
「② Entered into a sales partnership agreement for KANEKA CORPORATION’s new cerebral aneurysm embolization coil in the U.S. market」
The US sales alliance agreement for KANEKA CORPORATION’s new cerebral aneurysm embolisation coil is being reaffirmed as an initiative to expand its cerebrovascular product lineup. - FY2022-Q1First statedAnnual report
「② Entered into a sales partnership agreement for KANEKA CORPORATION’s new cerebral aneurysm embolization coil in the U.S. market」
The company entered into a US sales alliance agreement for KANEKA CORPORATION’s new cerebral aneurysm embolisation coil. This is a new initiative to expand its cerebrovascular product lineup and overseas sales opportunities.